It was reported that the presence of tumor-infiltrating lymphocytes (TIL) is related to a favorable outcome in breast cancer patients, thus CD8+T cells are considered as a crucial determinant of favorable clinical outcomes (28). Here, CD8A is linked to breast carcinoma.